found that the supernatant from saccharomyces boulardii (SB) activates FXR, thus inhibiting NLRP3 expression and preventing macrophage apoptosis in DSS-induced colitis mice, which significantly improves the symptoms of colitis. This evidence concerns the gene NLRP3 and colitis.